Skip to main content
. Author manuscript; available in PMC: 2019 Nov 15.
Published in final edited form as: Biotechnol Adv. 2018 Aug 27;36(7):1984–2016. doi: 10.1016/j.biotechadv.2018.08.008

Table 6:

Metal/metal oxide NPs synthesized by gum fibers and their electrospun functional membranes for antibacterial efficiencies.

Composition of
NPs
Type of bacteria tested Size and concentration
of NPs
Antibacterial susceptibility of bacterial
strains towards NPs (ZOIa/MIC b/MBC
c)
References
PVA/GA/Ag NP E. coli 10–40 nm; GA (5%), PVA (3%), AgNO3 (1mM) Not defined (Juby et al., 2012)
GA/DETA microgels E. coli, S. aureus 5–100 μm 5 mg/mL (E. coli),
10 mg/mL (S. aureus)
(Farooq et al., 2017)
GA /poly(sodium acrylate)/Ag NPs hydrogel E. coli 20–30 nm; GA (1 g); Na-acrylate (10.63 mmol), AgNO3 (0.117 mmol) Not defined (Bajpai and Kumari, 2015)
GA /poly (acrylate) hydrogel/ ZnO NPs E. coli 40–60 nm; ZnO (2%), GA (1.0g) 32 ± 0.07 mm (Bajpai et al., 2016)
GT/ ZnO nanorod E. coli, S. aureus, C. albicans 55–80 nm; Zn(NO3)2·6H2O (0.1M), GT (1%) 3.3 ± 0.1 mm (E. coli), 3.2 ± 0.1 mm (S. aureus), 3.0 ± 0.1 mm (C. albicans) (Ghayempour et al., 2016)
GT/nano silver hydro citric acid and sodium hypophosphite hydrogel on cotton fabric E. coli, S. aureus 77.55 nm; TG (0.8%),
AgNO3 (0.335%)
Reduction number of colonies 98.0% (E. coli) and 99.69% (S. aureus) (Montazer et al., 2016)
GT/PVA NF S. aureus, P. aeruginosa 40%(GT), 60% (PVA) good antimicrobial properties against (P. aeruginosa)
(Ranjbar-Mohammadi et al., 2013)
GK/Dodecenyl succinic anhydride (DDSA) composite E. coli, P. Aeruginosa, and
S. aureus
GK/DDSA (10%) Gram-negative E. coli (14.2 ± 0.8 mm); P. aeruginosa and Gram-positive S. aureus (15.0 ± 0.8 mm), respectively for 10 wt.% concentration of DDSA/DGK (Padil et al., 2015b)
GK/CuO NPs 4.8 ± 1.6 nm; CuCl2 ⋅ 2H2O (1 mM) and GK (10 mg/mL) S. aureus (25923) 14.5 ± 0.8 nm; E. coli (25922), 16.2 ± 0.8 mm. (Thekkae Padil and Černík, 2013)
KG / Ag NPs Gram-negative (Escherichia coli (ATCC 25922), E. coli (ATCC 35218), Pseudomonas aeruginosa (ATCC 27853) and Gram-positive (Staphylococcus aureus (ATCC 25923) 4.5± 3.1 nm; 0.5% KG (0.5%) and AgNO3 (1 mM) The minimum inhibitory concentration (MIC) for S. aureus (10 μg/mL); P. aeruginosa (5 μg/mL) and E. Coli (2.0 μg/mL). The minimum bactericidal concentration (MBC) of silver NPs against test bacterial strains for both S. aureus and P. aeruginosa (12 μg/mL) each and E. coli ( 2μg/mL) (Kora and Rastogi, 2015)
KG-Ag NPs S. aureus (ATCC 25923; ATCC 49834); E. coli
(ATCC 25922) and P. aeruginosa (ATCC 27853)
5.8 ± 2.4 nm;
GK-Ag NPs (1μg/mL)
E. coli (25922) 3.0 ug/mL; P. aeruginosa (27853) 5.0 ug/mL; S. aureus (25923) 5.0 ug/mL; S. aureus (49834) 5.0 ug/mL (Rastogi et al., 2015)
KG / gelatin sponge cipro floxacin S. aureus and E. coli GK (1% w/v) and gelatin (3% w/v) S. aureus (20 mm) and E. coli (25 mm) (Rathore et al., 2016)
KG/ Ag NPs S. aureus (ATCC 25923); and Escherichia coli (ATCC 25922), E. coli
(ATCC 35218) and Pseudomonas aeruginosa (ATCC 27853)
KG (0.5%) and AgNO3
(1.0 mM)
S. aureus (ATCC;
25923), 11 mm;
E. coli (ATCC 25922), 8.0 mm; E. coli (ATCC 35218), 8.4 mm; and P. aeruginosa (ATCC 27853),
8.7 mm
(Kora et al., 2010)
Dodecenyl succinic anhydride (DDSA)/ deacetylated KG fibers and membranes Gram-negative Escherichia coli (CCM 3954) and Pseudomonas aeruginosa (CCM 3955) and Gram-positive Staphylococcus aureus (CCM 3953) (PVA, 10 wt%) and DDSA/DGK (10 wt%) E. coli (8.0±0.1 mm, 6.0±0.5 mm); P. aeruginosa (7.0±0.1, 4.5±0.6);
S. aureus (9.0±0.1, 7.0±0.8)

(Padil et al., 2015a)
GG/ Ag NPs Staphylococcus aureus (ATCC 25923); and
Escherichia coli (ATCC 25922), E. coli (ATCC 35218),
and Pseudomonas aeruginosa (ATCC 27853)
5.7 ± 0.2 nm
0.1% GG and 1 mMAgNO3
5 μg of silver NPs
S. aureus, 25923 (12.25 mm); E. coli 25922 (9 mm); E. coli 35218 (8 mm); P. aeruginosa 27853 (11 mm) (Kora and Sashidhar, 2015)

aZone of inhibition (ZOI)

bminimum inhibitory concentration (MIC)

cminimum bactericidal concentration (MBC)